The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
A microfluidic 3D hepatocyte chip for drug toxicity testing
Abstract
We have developed a microfluidic 3D hepatocyte chip (3D HepaTox Chip) for in vitro drug toxicity testing to predict in vivo drug hepatotoxicity. The 3D HepaTox Chip is based on multiplexed microfluidic channels where a 3D microenvironment is engineered in each channel to maintain the hepatocytes' synthetic and metabolic functions. The multiplexed channels allow for simultaneous administration of multiple drug doses to functional primary hepatocytes while an incorporated concentration gradient generator enables the in vitro dose-dependent drug responses to predict in vivo hepatotoxicity. The IC(50) values of 5 model drugs derived from the dose-dependent on-chip testing correlate well with the reported in vivo LD(50) values. The 3D HepaTox Chip can be integrated with on-chip sensors and actuators as the next generation cell-based on-chip drug testing platform.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chapter 4 Preparation of Isolated Rat Liver Cells
Seglen, P. O. (1976) · Methods in Cell Biology · doi:10.1016/s0091-679x(08)61797-5 · Cited by 5,310
The price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
DrugBank: a knowledgebase for drugs, drug actions and drug targets
Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,861
Drug Metabolism and Disposition
(2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12259_4 · Cited by 2,515
El-Ali, J., Sorger, P. K., & Jensen, K. F. (2006) · Nature · doi:10.1038/nature05063 · Cited by 2,102
Lab-on-a-chip: microfluidics in drug discovery
Dittrich, P. S., & Manz, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1985 · Cited by 1,844
Microscale culture of human liver cells for drug development
Khetani, S. R., & Bhatia, S. N. (2008) · Nature Biotechnology · doi:10.1038/nbt1361 · Cited by 1,219
Hewitt, N. J., Gómez Lechón, M. J., Houston, J. B., Hallifax, D., Brown, H. S., Maurel, P., Kenna, J. G., Gustavsson, L., Lohmann, C., Skonberg, C., et al. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530601093489 · Cited by 735
An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons
Brandon, E. F. A., Raap, C. D., Meijerman, I., Beijnen, J. H., & Schellens, J. H. M. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00128-5 · Cited by 567
Lee, P. J., Hung, P. J., & Lee, L. P. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21360 · Cited by 509
A practical guide to microfluidic perfusion culture of adherent mammalian cells
Kim, L., Toh, Y.-C., Voldman, J., & Yu, H. (2007) · Lab on a Chip · doi:10.1039/b704602b · Cited by 455
Self-citationA novel 3D mammalian cell perfusion-culture system in microfluidic channels
Toh, Y.-C., Zhang, C., Zhang, J., Khong, Y. M., Chang, S., Samper, V. D., van Noort, D., Hutmacher, D. W., & Yu, H. (2007) · Lab on a Chip · doi:10.1039/b614872g · Cited by 414
Self-citationKang, L., Chung, B. G., Langer, R., & Khademhosseini, A. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.003 · Cited by 325
Sivaraman, A., Leach, J., Townsend, S., Iida, T., Hogan, B., Stolz, D., Fry, R., Samson, L., Tannenbaum, S., & Griffith, L. (2005) · Current Drug Metabolism · doi:10.2174/138920005774832632 · Cited by 310
Liver-Specific Functional Studies in a Microfluidic Array of Primary Mammalian Hepatocytes
Kane, B. J., Zinner, M. J., Yarmush, M. L., & Toner, M. (2006) · Analytical Chemistry · doi:10.1021/ac051856v · Cited by 264
Structural Polarity and Functional Bile Canaliculi in Rat Hepatocyte Spheroids
Abu-Absi, S. F., Friend, J. R., Hansen, L. K., & Hu, W.-S. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5467 · Cited by 230
Nanoliter scale microbioreactor array for quantitative cell biology
Lee, P. J., Hung, P. J., Rao, V. M., & Lee, L. P. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.20745 · Cited by 212
Goldkind, L., & Laine, L. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1207 · Cited by 178
New Technologies and Screening Strategies for Hepatotoxicity: Use of In Vitro Models
Dambach, D. M., Andrews, B. A., & Moulin, F. (2005) · Toxicologic Pathology · doi:10.1080/01926230590522284 · Cited by 177
A brief history of novel drug discovery technologies
Gershell, L. J., & Atkins, J. H. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1064 · Cited by 129
Membrane-Based PDMS Microbioreactor for Perfused 3D Primary Rat Hepatocyte Cultures
Ostrovidov, S., Jiang, J., Sakai, Y., & Fujii, T. (2004) · Biomedical Microdevices · doi:10.1023/b:bmmd.0000048560.96140.ca · Cited by 127
Trends in the development of microfluidic cell biochips for in vitro hepatotoxicity
Baudoin, R., Corlu, A., Griscom, L., Legallais, C., & Leclerc, É. (2006) · Toxicology in Vitro · doi:10.1016/j.tiv.2006.11.004 · Cited by 119
Hepatocyte Encapsulation for Enhanced Cellular Functions
Chia, S., Leong, K. W., Li, J., Xu, X., Zeng, K., Er, P.-N., Gao, S., & Yu, H. (2000) · Tissue Engineering · doi:10.1089/107632700750022134 · Cited by 117
Self-citationChan, L. L., Gosangari, S. L., Watkin, K. L., & Cunningham, B. T. (2007) · APOPTOSIS · doi:10.1007/s10495-006-0031-y · Cited by 110
Wang, K., Shindoh, H., Inoue, T., & Horii, I. (2002) · The Journal of Toxicological Sciences · doi:10.2131/jts.27.229 · Cited by 104
A linear dilution microfluidic device for cytotoxicity assays
Walker, G. M., Monteiro‐Riviere, N. A., Rouse, J. G., et al. (2006) · Lab on a Chip · doi:10.1039/b608990a · Cited by 96
Microfluidics: in search of a killer application
Blow, N. S. (2007) · Nature Methods · doi:10.1038/nmeth0807-665 · Cited by 80
Long-term culture of functional hepatocytes
Guillouzo, A., Morel, F., Ratanasavanh, D., et al. (1990) · Toxicology in Vitro · doi:10.1016/0887-2333(90)90092-8 · Cited by 75
Hewitt, N. J., de Kanter, R., & LeCluyse, E. L. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.12.009 · Cited by 72
Comparison of in vivo acute lethal potency and in vitro cytotoxicity of 48 chemicals
Shrivastava, R., Deloménie, C., Chevalier, A., et al. (1992) · Cell Biology and Toxicology · doi:10.1007/bf00260565 · Cited by 66
Cell-based microfluidic biochip for the electrochemical real-time monitoring of glucose and oxygen
PEREIRARODRIGUES, N., Sakai, Y., & Fujii, T. (2007) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2007.12.025 · Cited by 58
Mingoia, R. T., Nabb, D. L., Yang, C., & Han, X. (2006) · Toxicology in Vitro · doi:10.1016/j.tiv.2006.10.012 · Cited by 58
The future of microfluidic assays in drug development
Wen, Y., & Yang, S. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.10.1237 · Cited by 39
Toh, Y., Ng, S., Khong, Y. M., Samper, V., & Yu, H. (2005) · Assay and Drug Development Technologies · doi:10.1089/adt.2005.3.169 · Cited by 31
Self-citationMicrovalve‐assisted patterning platform for measuring cellular dynamics based on 3D cell culture
Kim, M. S., Lee, W., Kim, Y. C., & Park, J. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21962 · Cited by 23
In vivo perturbation of rat hepatocyte canalicular membrane function by diclofenac.
Sallustio, B. C., & Holbrook, F. L. (2001) · PubMed · Cited by 19
Toh, Y., Zhang, J., Khong, Y. M., Du, Y., Sun, W., & Yu, H. (2008) · The Analyst · doi:10.1039/b716420c · Cited by 5
Self-citation
Cited by
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Bhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
A guide to the organ-on-a-chip
Leung, C. M., de Haan, P., Ronaldson-Bouchard, K., Kim, G.-A., Ko, J., Rho, H. S., Chen, Z., Habibovic, P., Jeon, N. L., Takayama, S., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00118-6 · Cited by 1,116
Self-citationMicrofluidic technologies for accelerating the clinical translation of nanoparticles
Valencia, P. M., Farokhzad, O. C., Karnik, R., & Langer, R. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.168 · Cited by 698
Metadata
- Authors
- Toh, Y.-C., Lim, T. C., Tai, D., Xiao, G., van Noort, D., & Yu, H.
- Venue
- Lab on a Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2009
- Volume
- 9
- Issue
- 14
- Pages
- 2026
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- OpenAlex
- W2012867417
- Cited by
- 419
- References
- 37
- FWCI
- 14.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.